相关实验视频
Updated: Jun 17, 2025

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
35.7K
突变的p53通过调节EGR1来实现功能,从而诱导上皮层中介细胞过渡
Weipei Meng1, Shilong Yu2, Yan Li1
1Department of Toxicology, School of Public Health, Jilin University, Changchun, Jilin 130021, China.
Tissue & cell
|August 10, 2024
概括
肺癌中的p53-R273H突变通过激活EGR1促进转移,驱动上皮层-介质细胞过渡 (EMT). 针对这种途径为非小细胞肺癌 (NSCLC) 提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 皮质-介质细胞过渡 (EMT) 对于肺癌转移至关重要.
- 具有p53突变的非小细胞肺癌 (NSCLC) 显示出转移潜力的增加.
- 在转移中p53-R273H突变的特定作用需要进一步阐明.
研究的目的:
- 研究p53-R273H突变在促进肺癌转移中的作用.
- 阐明p53-R273H影响EMT和入侵的分子机制.
- 为了确定p53-R273H驱动的肺癌的潜在治疗点.
主要方法:
- 建立了一个表达p53-R273H突变的H1299细胞模型.
- 利用CCK-8,伤口愈合和Transwell测试来评估细胞增殖,迁移和入侵.
- 采用西方斑点,免疫光和ChIP-PCR来分析蛋白质表达和基因调节.
主要成果:
- 这种p53-R273H突变显著增强了细胞增殖,迁移,入侵和EMT.
- 在p53-R273H突变的细胞中,EGR1的表达被上调.
- 敲除EGR1抑制了EMT的进展,并且发现p53-R273H结合了EGR1促进体.
结论:
- 通过激活EGR1.1,p53-R273H突变驱动肺癌的进展和转移.
- 这种p53-R273H-EGR1信号轴代表了NSCLC的新型治疗点.
- 了解这种机制可以了解p53突变驱动的癌症发展.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K

